3月 2026
- 首頁
- Amicus Therapeutics, Inc.
3月 2026Amicus Therapeutics, Inc.的市場佔有率分析
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, PA. The company went public in 2007 under the NASDAQ trading symbol FOLD.
Amicus Therapeutics, Inc.(包含公司地區)
查看更多網站流量與參與度資訊- amicusrx.com
Amicus Therapeutics, Inc.截至 3月 2026 的總收入為 200M - 500M
Amicus Therapeutics, Inc. 熱門網域產生的總收入
Amicus Therapeutics, Inc. 熱門網域 3 年內的總收入
Amicus Therapeutics, Inc. 熱門網域的總收入
3月 2026Amicus Therapeutics, Inc.的股票價格
Amicus Therapeutics, Inc. 股票交易代碼 #FOLD。以下是截至 3月 2026Amicus Therapeutics, Inc. 過去 12 個月的股票績效
Amicus Therapeutics, Inc.的熱門網域總造訪量
了解Amicus Therapeutics, Inc.市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
Amicus Therapeutics, Inc.的熱門網域平均造訪時長
分析Amicus Therapeutics, Inc.參與度指標。
過去 3 個月平均造訪時長
子公司細目
Amicus Therapeutics, Inc.的熱門網域平均頁面瀏覽量
了解Amicus Therapeutics, Inc.如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自Amicus Therapeutics, Inc.
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Genomenon Inc. partnered with Amicus Therapeutics, Inc. on Mar 10th '26.Genomenon today announced a strategic sponsorship from Amicus Therapeutics to accelerate awareness, diagnosis, and research for Fabry disease.
3月 10, 2026閱讀更多
新聞BioMarin Pharmaceutical Inc. integrates with Amicus Therapeutics, Inc..The deal, approved by both boards, expands BioMarin's rare disease portfolio with Amicus' therapies for Fabry and Pompe diseases and adds high-growth revenue streams.
12月 19, 2025閱讀更多
新聞Amicus Therapeutics, Inc. attended event 43rd Annual J.P. Morgan Healthcare Conference on May 7th '25.PRINCETON, N.J., May 07, 2025 (GLOBE NEWSWIRE) - Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in a fireside chat at the Bank of America 2025 Health Care Conference in Las Vegas, NV on Wednesday, May 14, 2025, at 8:00 a.m. P.T.
5月 7, 2025閱讀更多
查看所有Amicus Therapeutics, Inc.信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。